STOCK TITAN

Denali Therapeutics: Option exercise covers 16,566 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Alexander O. Schuth, Denali Therapeutics Inc.'s COFO and Secretary, exercised options for 16,566 common shares at a $9.60 exercise price on November 17, 2026. After the exercise, his reported direct position was 295,561 common shares, including 135,475 unvested RSUs, and 40,075 options. Separately, 523,749 shares were held of record by The Schuth Family Trust, for which Schuth serves as trustee.

Insider Schuth Alexander O.
Role COFO and Secretary
Type Security Shares Price Value
Exercise Stock Option (right to buy) F3 16,566 $0.00 $0.00
Exercise Common Stock F1 16,566 $9.60 $159K
Holding Common Stock F2 -- -- --
Holdings After Transaction: Stock Option (right to buy) — 40,075 options (Direct); Common Stock — 295,561 shares (Direct); Common Stock — 523,749 shares (Indirect, See footnote)
Footnotes (3)
  1. F1. Includes 135,475 Unvested RSUs.
  2. F2. The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
  3. F3. 25% of the shares subject to the option vested on August 22, 2018 and an additional 1/48 of the shares vest monthly thereafter.
Options exercised 16,566 shares Exercise on November 17, 2026, to acquire common stock.
Exercise price $9.60 per share Option exercise on November 17, 2026.
Direct common shares after transaction 295,561 shares Includes 135,475 unvested RSUs.
Options after transaction 40,075 options Reported direct option position after exercise.
Indirect common shares 523,749 shares Held of record by The Schuth Family Trust; Schuth serves as trustee.
Unvested RSUs technical
"Includes 135,475 Unvested RSUs."
vested technical
"25% of the shares subject to the option vested on August 22, 2018"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DNLI shares did Alexander O. Schuth acquire through option exercise?

He exercised options to acquire 16,566 common shares at a $9.60 exercise price on November 17, 2026. His reported direct common-stock position after the transaction was 295,561 shares, including 135,475 unvested RSUs; his reported option position was 40,075.

What was the vesting schedule for Alexander O. Schuth's Denali options?

The option schedule provided that 25% of the shares subject to the option vested on August 22, 2018, with an additional 1/48 vesting monthly thereafter.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schuth Alexander O.

(Last)(First)(Middle)
C/O DENALI THERAPEUTICS INC.
161 OYSTER POINT BLVD.

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Denali Therapeutics Inc. [ DNLI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
COFO and Secretary
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/17/2026M16,566A$9.6295,561(1)D
Common Stock523,749ISee footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$9.611/17/2026M16,566 (3)08/22/2027Common Stock16,566$040,075D
Explanation of Responses:
1. Includes 135,475 Unvested RSUs.
2. The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
3. 25% of the shares subject to the option vested on August 22, 2018 and an additional 1/48 of the shares vest monthly thereafter.
Remarks:
/s/ Tyler Nielsen, by power of attorney11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading